Literature DB >> 5214334

A rating system for neurological impairment in multiple sclerosis.

E Pedersen.   

Abstract

Entities:  

Mesh：

Year:  1965        PMID： 5214334     DOI： 10.1111/j.1600-0404.1965.tb01929.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN： 0065-1427


× No keyword cloud information.
  3 in total

Review 1.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

2.  Tizanidine in the treatment of spasticity.

Authors:  P M Newman; M Nogues; P K Newman; D Weightman; P Hudgson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.

Authors:  Concetta De Pasquale; Maria Luisa Pistorio; Massimiliano Veroux; Alessia Giaquinta; Pierfrancesco Veroux; Michele Fornaro
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-11       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.